HOT TOPIC: Zika Virus – What We Have Learned and A Review of FDA’s 2018 Zika Guidance

Please note: AABB reserves the right to make updates to this program.

Friday, December 7, 2018 – Please note this program is on a Friday
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-375 (see program format numbers below under Registration)

Educational Track: Scientific
Topic: Transfusion Medicine
Intended Audience: CEOs, COOs, Directors, Facilities that perform molecular testing, Hospitals, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Resident/Fellow, Scientists, Students (MD, MT, SBB), Technologists
Teaching Level: Intermediate

Director/Moderator: Suchi Pandey, MD, Chief Medical Officer, Stanford Blood Center, Associate Clinical Professor, Stanford School of Medicine, Palo Alto, CA
Speakers: Michael P. Busch, MD, PhD, Vitalant Research Institute Director, Senior VP of Research and Scientific Programs, Vitalant, Professor, Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Discuss at least 3 key things we have learned about Zika Virus (ZIKV) infection since the recent epidemics.
  • Review data compiled from testing US Blood Donors for ZIKV NAT using different investigational NAT testing platforms.
  • Review the recommendations in the FDA’s 2018 Revised ZIKV Guidance.
  • Discuss the cost effectiveness of MP-NAT and ID-NAT ZIKV testing in US blood donors.

Program Description

Although some questions still remain unanswered about Zika virus (ZIKV), numerous studies performed during the recent epidemics have increased our understanding of ZIKV. This program will provide an overview of new information gained about ZIKV, such as modes of transmission, clinical consequences of infection, viral persistence in blood and other body fluids, and risk in blood donors. Data from testing of blood donors in the US using two investigational NAT tests will be reviewed. Speakers will also review recommendations in the FDA’s July 2018 revised ZIKV Guidance including the evidence that supports the use mini-pool nucleic acid testing (MP-NAT) with switch to individual donation nucleic acid testing (ID-NAT testing) in certain conditions. The cost effectiveness of MP-NAT and ID-NAT testing for ZIKV will also be discussed.

Registration

   Program #
Single Viewer: Live Register18EL-375-2035
Single Viewer: On-Demand Register18EL-375-4035
Group Viewing: Live Register18EL-375-6035
Group Viewing: On-Demand Register18EL-375-8035
Group Viewing: Live & On-Demand Register18EL-375-9935

Continuing Education Credit

AABB estimates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credit/contact hour for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.

Speaker Biographies

Dr. Michael Busch is the Director of Vitalant Research Institute, Senior Vice President for Research & Scientific Programs of Vitalant, and Professor of Laboratory Medicine at the University of California, San Francisco. He earned his Bachelor of Science degree from the UCSB, and his MS, MD and PhD degrees from the UCSC and completed his residency at UCSF. He has played a leadership role in a number of national multi-center research studies funded by NIH and CDC contracts and has directed numerous NIH and CDC grant-funded studies based at the Research Institute and conducted in collaboration with UCSF, UCB and other national and international institutions. Dr. Busch has published nearly 500 peer-reviewed original scientific articles, and over 150 review articles, editorials and book chapters.

Dr. Suchi Pandey is the Chief Medical Officer of the Stanford Blood Center and Associate Clinical Professor in the Department of Pathology in the Stanford School of Medicine. Her responsibilities include providing medical support to Stanford’s blood center and transfusion service. Dr. Pandey received an MD from Drexel University College of Medicine in Philadelphia and completed an Anatomic and Clinical Pathology (APCP) residency at UCSD and a Transfusion Medicine (TM) fellowship at UCSF. She is Board Certified in APCP and TM. Dr Pandey is actively involved in the transfusion medicine community and currently serves on the board of directors for the California Blood Bank Society. She also co-chairs the Blood Center of California’s Medical Advisory Committee and serves on educational committees for ABC and AABB. Her interests include transfusion medicine education and expanding the Blood Center’s role in research initiatives.